1145665

Blair M. Brengle, M.D. — FEI 3018034336

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 8, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent